Leotta C, Barbaraci C, Fiorito J, Coco A, di Giacomo V, Amata E
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40005993
PMC: 11859726.
DOI: 10.3390/ph18020179.
Liu C, Mottinelli M, Nicholson H, McVeigh B, Wong N, McCurdy C
Eur J Pharmacol. 2021; 906:174263.
PMID: 34144027
PMC: 8736263.
DOI: 10.1016/j.ejphar.2021.174263.
Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T
Molecules. 2020; 25(22).
PMID: 33233619
PMC: 7699687.
DOI: 10.3390/molecules25225439.
Motawe Z, Abdelmaboud S, Cuevas J, Breslin J
Int J Biochem Cell Biol. 2020; 126:105803.
PMID: 32668330
PMC: 7484451.
DOI: 10.1016/j.biocel.2020.105803.
Oyer H, Sanders C, Kim F
Front Pharmacol. 2019; 10:1141.
PMID: 31695608
PMC: 6816035.
DOI: 10.3389/fphar.2019.01141.
Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands.
Iyamu I, Lv W, Malik N, Mishra R, Schiltz G
ChemMedChem. 2019; 14(13):1248-1256.
PMID: 31071238
PMC: 6613831.
DOI: 10.1002/cmdc.201900203.
SYA 013 analogs as moderately selective sigma-2 (σ) ligands: Structure-affinity relationship studies.
Al-Ghanim L, Zhu X, Asong G, Ablordeppey S
Bioorg Med Chem. 2019; 27(12):2421-2426.
PMID: 30737135
PMC: 6536313.
DOI: 10.1016/j.bmc.2019.01.035.
Sigma Receptors as Endoplasmic Reticulum Stress "Gatekeepers" and their Modulators as Emerging New Weapons in the Fight Against Cancer.
Tesei A, Cortesi M, Zamagni A, Arienti C, Pignatta S, Zanoni M
Front Pharmacol. 2018; 9:711.
PMID: 30042674
PMC: 6048940.
DOI: 10.3389/fphar.2018.00711.
Morphine: double-faced roles in the regulation of tumor development.
Zhang X, Liang Y, Yan Y, Dai Z, Chu H
Clin Transl Oncol. 2017; 20(7):808-814.
PMID: 29127594
DOI: 10.1007/s12094-017-1796-x.
Cloning the sigma receptor: Wandering 40 years to find an identity.
Kim F, Pasternak G
Proc Natl Acad Sci U S A. 2017; 114(27):6888-6890.
PMID: 28645899
PMC: 5502656.
DOI: 10.1073/pnas.1708155114.
Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands.
Bai S, Li S, Xu J, Peng X, Sai K, Chu W
J Med Chem. 2014; 57(10):4239-51.
PMID: 24821398
PMC: 6818095.
DOI: 10.1021/jm5001453.
The σ2 receptor: a novel protein for the imaging and treatment of cancer.
Mach R, Zeng C, Hawkins W
J Med Chem. 2013; 56(18):7137-60.
PMID: 23734634
PMC: 4064612.
DOI: 10.1021/jm301545c.
Inhibitory effects of sigma-2 receptor agonists on T lymphocyte activation.
Iniguez M, Punzon C, Nieto R, Burgueno J, Vela J, Fresno M
Front Pharmacol. 2013; 4:23.
PMID: 23494519
PMC: 3595506.
DOI: 10.3389/fphar.2013.00023.
Development of benzophenone-alkyne bifunctional sigma receptor ligands.
Guo L, Hajipour A, Karaoglu K, Mavlyutov T, Ruoho A
Chembiochem. 2012; 13(15):2277-89.
PMID: 23001760
PMC: 3517089.
DOI: 10.1002/cbic.201200427.
Sigma-2 ligands induce tumour cell death by multiple signalling pathways.
Zeng C, Rothfuss J, Zhang J, Chu W, Vangveravong S, Tu Z
Br J Cancer. 2012; 106(4):693-701.
PMID: 22251921
PMC: 3322954.
DOI: 10.1038/bjc.2011.602.
Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes.
Zeng C, Vangveravong S, Jones L, Hyrc K, Chang K, Xu J
Mol Imaging. 2011; 10(6):420-33.
PMID: 22201533
PMC: 4426860.
Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.
Seminerio M, Robson M, Abdelazeem A, Mesangeau C, Jamalapuram S, Avery B
AAPS J. 2011; 14(1):43-51.
PMID: 22183188
PMC: 3291180.
DOI: 10.1208/s12248-011-9311-8.
Targeting sigma receptors: novel medication development for drug abuse and addiction.
Matsumoto R
Expert Rev Clin Pharmacol. 2011; 2(4):351-8.
PMID: 22112179
PMC: 3662539.
DOI: 10.1586/ecp.09.18.
AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells.
Kaushal N, Elliott M, Robson M, Iyer A, Rojanasakul Y, Coop A
Mol Pharmacol. 2011; 81(3):299-308.
PMID: 22101517
PMC: 3286303.
DOI: 10.1124/mol.111.074120.
Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand.
Hajipour A, Guo L, Pal A, Mavlyutov T, Ruoho A
Bioorg Med Chem. 2011; 19(24):7435-40.
PMID: 22055714
PMC: 3229200.
DOI: 10.1016/j.bmc.2011.10.046.